Related Experiment Video
Updated: Jan 11, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
The Effects of Carbohydrate Counting Over Glycometabolic Control in Patients Diagnosed with Type 1 Diabetes Mellitus
Aysa Hacioglu1, Ilknur Uzun1, Zuleyha Karaca1
1Department of Endocrinology, Erciyes University, Faculty of Medicine, Kayseri, Türkiye.
Objective:
Advanced carbohydrate counting (CC), a nutritional intervention that adjusts insulin based on the estimated carbohydrate content of meals, has shown inconsistent effects on glycometabolic control. This study aimed to evaluate the long-term efficacy of advanced CC in patients with type 1 diabetes mellitus (DM) and assess adherence and consistency rates.
Materials And Methods:
Adult patients diagnosed with type 1 DM who applied multiple dose insulin therapy were included. Data from patients who completed advanced CC training and practiced it for at least 3 months were retrospectively reviewed. Baseline demographic data, as well as BMI, HbA1c, lipid profile, daily insulin doses, meal frequency, hospital visits, and chronic complication rates, were evaluated before and after CC.
Results:
Twenty-five patients (mean± SD age: 22.6±7.7 years, 68% female) were included. The duration of CC was a median (IQR) of 40 (12-75) months. HbA1c levels significantly improved (p=0.023), while BMIs and lipid parameters remained similar. Four patients experienced diabetic ketoacidosis in the year before starting CC and none during follow-up (p=0.046). None of the patients had new-onset diabetic complications during CC. The adherence rate was 69.5%, and the discontinuation rate was 32%. The primary reason for discontinuation was the difficulty in implementing the method daily.
Conclusion:
Advanced CC is effective for improving glycemic control in patients with type 1 DM, with effects that last for a long time. Consistency may be hindered for some patients by difficulties integrating it into their daily life. Dietary and lifestyle advice should be individualized in patients with type 1 DM.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
Related Concept Videos
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...